News & Updates

Show Multimedia Only
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

17 Mar 2022 byRoshini Claire Anthony

Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.

Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

17 Mar 2022
Ocular biometrics help predict progression of primary angle closure disease

Ocular biometrics help predict progression of primary angle closure disease

17 Mar 2022
DOAC use persists in NVAF patients with liver disease

DOAC use persists in NVAF patients with liver disease

17 Mar 2022
Antihypertensive drugs up risk of psoriasis

Antihypertensive drugs up risk of psoriasis

17 Mar 2022

Use of antihypertensive medications is associated with the incidence of psoriasis, reports a study. Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers (CCBs), and thiazide diuretics result in an increased risk of psoriasis.

Antihypertensive drugs up risk of psoriasis

17 Mar 2022